BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 16579884)

  • 1. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
    Ellekvist P; Colding H
    Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum.
    Sanchez CP; Stein WD; Lanzer M
    Trends Parasitol; 2007 Jul; 23(7):332-9. PubMed ID: 17493873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane transport proteins of the malaria parasite.
    Martin RE; Ginsburg H; Kirk K
    Mol Microbiol; 2009 Nov; 74(3):519-28. PubMed ID: 19796339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine transport via the malaria parasite's chloroquine resistance transporter.
    Martin RE; Marchetti RV; Cowan AI; Howitt SM; Bröer S; Kirk K
    Science; 2009 Sep; 325(5948):1680-2. PubMed ID: 19779197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China.
    Zhang GQ; Guan YY; Zheng B; Wu S; Tang LH
    Trop Med Int Health; 2009 Oct; 14(10):1266-71. PubMed ID: 19772548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.
    Happi CT; Gbotosho GO; Folarin OA; Bolaji OM; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Am J Trop Med Hyg; 2006 Jul; 75(1):155-61. PubMed ID: 16837724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum chloroquine resistance marker protein (Pfcrmp) may be a chloroquine target protein in nucleus.
    Li GD
    Med Hypotheses; 2007; 68(2):332-4. PubMed ID: 16997492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
    Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
    Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel transporter, Pfcrt, confers antimalarial drug resistance.
    Howard EM; Zhang H; Roepe PD
    J Membr Biol; 2002 Nov; 190(1):1-8. PubMed ID: 12422267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroquine mediates specific proteome oxidative damage across the erythrocytic cycle of resistant Plasmodium falciparum.
    Radfar A; Diez A; Bautista JM
    Free Radic Biol Med; 2008 Jun; 44(12):2034-42. PubMed ID: 18397762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary paradigm of chloroquine-resistant malaria in India.
    Das A; Dash AP
    Trends Parasitol; 2007 Apr; 23(4):132-5. PubMed ID: 17280870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A class of potent antimalarials and their specific accumulation in infected erythrocytes.
    Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ
    Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the export pathway of malaria surface proteins.
    Epp C; Deitsch K
    Trends Parasitol; 2006 Sep; 22(9):401-4. PubMed ID: 16843728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
    Qidwai T; Khan F
    Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transporters as mediators of drug resistance in Plasmodium falciparum.
    Sanchez CP; Dave A; Stein WD; Lanzer M
    Int J Parasitol; 2010 Aug; 40(10):1109-18. PubMed ID: 20399785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious diseases. Candidate drug breaks down malaria's walls.
    Taubes G
    Science; 2002 Feb; 295(5558):1207-9. PubMed ID: 11847313
    [No Abstract]   [Full Text] [Related]  

  • 17. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
    Tuteja R
    FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein targeting from malaria parasites to host erythrocytes.
    Römisch K
    Traffic; 2005 Aug; 6(8):706-9. PubMed ID: 15998325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.
    Ojurongbe O; Ogungbamigbe TO; Fagbenro-Beyioku AF; Fendel R; Kremsner PG; Kun JF
    Malar J; 2007 Apr; 6():41. PubMed ID: 17428334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cAMP-dependent protein kinase from Plasmodium falciparum: an update.
    Wurtz N; Chapus C; Desplans J; Parzy D
    Parasitology; 2011 Jan; 138(1):1-25. PubMed ID: 20663247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.